Trevi Therapeutics Inc. (TRVI)
undefined
undefined%
At close: undefined
4.17
0.00%
After-hours Dec 13, 2024, 07:58 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue - - - - - - - -
Cost of Revenue 123.00K 43.00K 50.00K 47.00K 39.00K 23.00K - 4.00K
Gross Profit -123.00K -43.00K -50.00K -47.00K -39.00K -23.00K - -4.00K
Operating Income -33.92M -29.91M -32.48M -32.49M -26.64M -18.41M -8.24M -8.63M
Interest Income 4.75M 1.74M 10.00K 178.00K 792.00K 156.00K 69.00K 2.61M
Pretax Income -29.10M -29.19M -33.96M -32.78M -26.07M -20.67M -12.89M -11.10M
Net Income -29.07M -29.15M -33.94M -32.76M -26.05M -20.55M -12.86M -11.09M
Selling & General & Admin 10.24M 10.07M 9.49M 10.16M 7.31M 4.34M 2.14M 1.71M
Research & Development 23.68M 19.83M 22.98M 22.33M 19.34M 14.07M 6.09M 6.91M
Other Expenses - 719.00K -375.00K -287.00K 577.00K -2.24M -24.00K -
Operating Expenses 33.92M 29.91M 32.48M 32.49M 26.64M 18.41M 8.24M 8.62M
Interest Expense 391.00K 780.00K 1.20M 456.00K - 174.00K 3.34M -
Selling & Marketing Expenses 287.00K - - - - - - 50.00K
Cost & Expenses 33.92M 29.91M 32.48M 32.49M 26.64M 18.41M 8.24M 8.63M
Income Tax -32.00K -36.00K -21.00K -18.00K -18.00K -124.00K -26.00K -8.00K
Shares Outstanding (Basic) 99.03M 64.54M 22.84M 18.06M 11.74M 8.97M 8.97M 16.14M
Shares Outstanding (Diluted) 99.03M 64.54M 22.84M 18.06M 11.74M 8.97M 8.97M 16.14M
EPS (Basic) -0.29 -0.45 -1.49 -1.81 -2.22 -2.29 -1.43 -0.69
EPS (Diluted) -0.29 -0.45 -1.49 -1.81 -2.22 -2.29 -1.43 -0.69
EBITDA -33.80M -29.86M -32.43M -32.44M -26.61M -18.39M -8.19M -8.62M
Depreciation & Amortization 123.00K 43.00K 50.00K 47.00K 39.00K 23.00K 4.00K 4.00K